Gloria Hernández-Alcántara

Dr. Gloria Hernández-Alcántara

Facultad de Medicina, UNAM, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SGSaul Gomez-Manzo
Saul Gomez-Manzo
JTJessica Terrón-Hernández
Jessica Terrón-Hernández
Ignacio De la Mora De la MoraIgnacio De la Mora De la Mora
Ignacio De la Mora De la Mora
AGAbigail González-Valdez
Abigail González-Valdez
JMJaime Marcial-Quino
Jaime Marcial-Quino
SESergio Enriquez-Flores
Sergio Enriquez-Flores
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency worldwide, causing a wide spectrum of conditions with severity classified from the mildest (Class IV) to the most severe (Class I). To correlate mutation sites in the G6PD with the resulting phenotypes, we studied four naturally occurring G6PD variants: Yucatan, Nashville, Valladolid and Mexico City. For this purpose, we developed a successful over-expression method that constitutes an easier and more precise method for obtaining and characterizing these enzymes. The kcat (catalytic constant) of all the studied variants was lower than in the wild-type. The structural rigidity might be the cause and the most evident consequence of the mutations is their impact on protein stability and folding, as can be observed from the protein yield, the T50 (temperature where 50% of its original activity is retained) values, and differences on hydrophobic regions. The mutations corresponding to more severe phenotypes are related to the structural NADP+ region. This was clearly observed for the Classes III and II variants, which became more thermostable with increasing NADP+, whereas the Class I variants remained thermolabile. The mutations produce repulsive electric charges that, in the case of the Yucatan variant, promote increased disorder of the C-terminus and consequently affect the binding of NADP+, leading to enzyme instability.

1 February 2008 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
SESergio Enriquez-Flores
Sergio Enriquez-Flores
ARAdela Rodriguez-Romero
Adela Rodriguez-Romero
Gloria Hernández-AlcántaraGloria Hernández-Alcántara
Gloria Hernández-Alcántara
Ignacio De la Mora De la MoraIgnacio De la Mora De la Mora
Ignacio De la Mora De la Mora
PGPedro Gutierrez-Castrellon
Pedro Gutierrez-Castrellon
HRHoracio Reyes-Vivas
Horacio Reyes-Vivas

16 June 2011 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
SESergio Enriquez-Flores
Sergio Enriquez-Flores
ARAdela Rodriguez-Romero
Adela Rodriguez-Romero
Gloria Hernández-AlcántaraGloria Hernández-Alcántara
Gloria Hernández-Alcántara
JOJesús Oria-Hernández
Jesús Oria-Hernández
PGPedro Gutiérrez‐Castrellón
Pedro Gutiérrez‐Castrellón
HRHoracio Reyes-Vivas
Horacio Reyes-Vivas

1 March 2003 in Biochemistry
Verified
Journal Article
Closed access
VZViviana Zomosa-Signoret
Viviana Zomosa-Signoret
Gloria Hernández-AlcántaraGloria Hernández-Alcántara
Gloria Hernández-Alcántara
HRHoracio Reyes-Vivas
Horacio Reyes-Vivas
EMEduardo Martinez-Martinez
Eduardo Martinez-Martinez
GGGeorgina Garza-Ramos
Georgina Garza-Ramos
AGArmando Gómez-Puyou
Armando Gómez-Puyou

1 December 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
HRHoracio Reyes-Vivas
Horacio Reyes-Vivas
Ignacio De la Mora De la MoraIgnacio De la Mora De la Mora
Ignacio De la Mora De la Mora
ACAdriana Castillo
Adriana Castillo
LYLilian Yépez-Mulia
Lilian Yépez-Mulia
Gloria Hernández-AlcántaraGloria Hernández-Alcántara
Gloria Hernández-Alcántara
Gabriel López-VelázquezGabriel López-Velázquez
Gabriel López-Velázquez
Giardiasis is highly prevalent in the developing world, and treatment failures with the standard drugs are common. This work deals with the proposal of omeprazole as a novel antigiardial drug, focusing on a giardial glycolytic enzyme used to follow the cytotoxic effect at the molecular level. We used recombinant technology and enzyme inactivation to demonstrate the capacity of omeprazole to inactivate giardial triosephosphate isomerase, with no adverse effects on its human counterpart. To establish the specific target in the enzyme, we used single mutants of every cysteine residue in triosephosphate isomerase. The effect on cellular triosephosphate isomerase was evaluated by following the remnant enzyme activity on trophozoites treated with omeprazole. The interaction of omeprazole with giardial proteins was analyzed by fluorescence spectroscopy. The susceptibility to omeprazole of drug-susceptible and drug-resistant strains ofGiardia lambliawas evaluated to demonstrate its potential as a novel antigiardial drug. Our results demonstrate that omeprazole inhibits giardial triosephosphate isomerase in a species-specific manner through interaction with cysteine at position 222. Omeprazole enters the cytoplasmic compartment of the trophozoites and inhibits cellular triosephosphate isomerase activity in a dose-dependent manner. Such inhibition takes place concomitantly with the cytotoxic effect caused by omeprazole on trophozoites.G. lambliatriosephosphate isomerase (GlTIM) is a cytoplasmic protein which can help analyses of how omeprazole works against the proteins of this parasite and in the effort to understand its mechanism of cytotoxicity. Our results demonstrate the mechanism of giardial triosephosphate isomerase inhibition by omeprazole and show that this drug is effectivein vitroagainst drug-resistant and drug-susceptible strains ofG. lamblia.

1 March 1999 in Biochemistry
Verified
Journal Article
Closed access
RPRuy Perez-Montfort
Ruy Perez-Montfort
GGGeorgina Garza-Ramos
Georgina Garza-Ramos
Gloria Hernández-AlcántaraGloria Hernández-Alcántara
Gloria Hernández-Alcántara
HRHoracio Reyes-Vivas
Horacio Reyes-Vivas
XGXiu-Gong Gao
Xiu-Gong Gao
AGArmando Gómez-Puyou
Armando Gómez-Puyou